Results 121 to 130 of about 256,192 (186)

[Home Respiratory Therapies: SEPAR Technical Document for Institutional Decision Support]. [PDF]

open access: yesOpen Respir Arch
Marcos PJ   +4 more
europepmc   +1 more source

Predictive performance of fetal growth restriction criteria for adverse perinatal outcomes in a hospital in Popayán, Colombia [PDF]

open access: yesRev Colomb Obstet Ginecol, 2022
Gutiérrez-Montufar OO   +5 more
europepmc   +1 more source

[HEARTS quality: a policy framework to strengthen hypertension and cardiovascular risk management in primary healthcare - insights from HEARTS in the AmericasQualidade da iniciativa HEARTS: marco de políticas para fortalecer o manejo da hipertensão e do risco cardiovascular na atenção primária à saúde. Perspectivas da iniciativa HEARTS nas Américas]. [PDF]

open access: yesRev Panam Salud Publica
Londoño E   +21 more
europepmc   +1 more source

Arrhythmic mitral valve complex: diagnostic and therapeutic approach. [PDF]

open access: yesArch Cardiol Mex
Trujillo-Flores D   +3 more
europepmc   +1 more source

[Early orthodontic/orthopedic treatment in patients with class II sagittal anomalies. A review]. [PDF]

open access: yesRev Cient Odontol (Lima), 2023
Yánez-Zurita C   +2 more
europepmc   +1 more source

Methodologies for population surveys on violence in rural areas: a scoping review. [PDF]

open access: yesRev Esc Enferm USP
Bervig CLB   +5 more
europepmc   +1 more source

Estudio de PharmaMar, SA y Oryzon Genomics SA a través de sus estados de flujos de efectivo

open access: yes, 2019
With the aim of carrying out an analysis of the solvency and liquidity of a company through the study of its annual accounts (hereinafter, CCAA), it has been decided to analyze the companies PharmaMar, S.A and Oryzon Genomics, S.A. Both companies, due to the performance of their main activity, are included in the pharmaceutical and biotechnology ...
openaire   +1 more source

Home - About - Disclaimer - Privacy